A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL OF OLEOYLETHANOLAMIDE FOR TARGETING LIPID METABOLISM IN GULF WAR ILLNESS

$1,625,254FY2019Defense Health AgencyDOD

The Roskamp Institute, Inc.

Investigators